Anat Naschitz is a Managing Director at OrbiMed. OrbiMed is a preeminent global healthcare investment firm with ~$15 billion under management across public and private asset classes. The firm covers the entire healthcare spectrum, investing in biopharmaceuticals, medical devices and digital health. Anat has over 20 years of healthcare experience, and currently serves on the boards of biotech and digital health companies.
Previously Anat created, invested in and advised healthcare companies across stages and substance. She was an Associate Partner with McKinsey in London, where she managed strategy and M&A projects for senior management of the world’s leading pharmaceutical and biotechnology companies. Among other accomplishments, Anat led pharmaceutical spinout work resulting in the creation of European biotech companies valued at billions of dollars. Post McKinsey Anat joined Apax Partners, where she focused on life sciences investments. She earned her M.B.A. at INSEAD and her LL.B. at Tel Aviv University.